DSpace Repository

P38 inhibitor inhibits the apoptosis of cowanin-treated human colorectal adenocarcinoma cells

Show simple item record

dc.contributor.author Chowchaikong N.
dc.contributor.author Nilwarangkoon S.
dc.contributor.author Laphookhieo S.
dc.contributor.author Tanunyutthawongse C.
dc.contributor.author Watanapokasin R.
dc.date.accessioned 2021-04-05T03:22:37Z
dc.date.available 2021-04-05T03:22:37Z
dc.date.issued 2018
dc.identifier.issn 10196439
dc.identifier.other 2-s2.0-85045395183
dc.identifier.uri https://ir.swu.ac.th/jspui/handle/123456789/13177
dc.identifier.uri https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045395183&doi=10.3892%2fijo.2018.4353&partnerID=40&md5=79a225755790f03dd39f67ff640236ce
dc.description.abstract Colorectal cancer, which is the third most common type of cancer diagnosed in both men and women, is the leading cause of cancer-related deaths worldwide. Cowanin is a pure compound extracted from Garcinia cowa Roxb., a tree species present in Thailand, Malaysia and Myanmar. The crude extract has been demonstrated to have antitumor activity, inflammation induction, antibacterial activity, anti-inflammatory activity and antimalarial activity. In the present study, the effects of cowanin on apoptosis induction and on the apoptosis- related and mitogen-Activated protein kinase (MAPK) pathways were investigated in the LoVo human colorectal cancer cell line. The cytotoxicity of cowanin in LoVo cells was determined by MTT assay. Hoechst 33342 and JC-1 staining were used to determine nuclear morphological changes and mitochondrial membrane potential, respectively. The expression levels of BCL2 apoptosis regulator (Bcl-2) family, MAPK and AKT serine/threonine kinase 1 (Akt) pathway proteins following cowanin treatment were determined by western blot analysis. The results demonstrated that cowanin inhibited cell proliferation and induced cell death via the apoptosis pathway. Cowanin treatment increased BCL2 associated X (Bax) and decreased Bcl-2 expression. In addition, cowanin activated caspase-9, -7 and poly-ADP-ribose-polymerase expression. Furthermore, cowanin decreased the levels of phosphorylated extracellular signal-regulated kinase (p-ERK), p-Akt, p-3-phosphoinositide-dependent protein kinase-1, while it increased p-p38 expression, thus resulting in the induction of apoptosis. In conclusion, cowanin inhibited cell proliferation and induced apoptosis of LoVo cells via the MAPK and Akt signaling pathways. Notably, inhibition of p38 by using a p38 inhibitor (SB203580) prevented the cowanin-induced apoptosis in LoVo cells. These results suggested that cowanin may be a potential candidate for the treatment of colorectal cancer and provided important information on the molecular mechanisms underlying its antitumor activity. © 2018 Spandidos Publications. All rights reserved.
dc.subject antineoplastic agent
dc.subject caspase 7
dc.subject caspase 9
dc.subject cowanin
dc.subject hoe 33342
dc.subject mitogen activated protein kinase
dc.subject mitogen activated protein kinase p38 inhibitor
dc.subject nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase
dc.subject phosphoinositide dependent protein kinase 1
dc.subject protein Bax
dc.subject protein bcl 2
dc.subject protein kinase B
dc.subject unclassified drug
dc.subject xanthone derivative
dc.subject 4 (4 fluorophenyl) 2 (4 methylsulfinylphenyl) 5 (4 pyridyl)imidazole
dc.subject CASP7 protein, human
dc.subject CASP9 protein, human
dc.subject caspase 7
dc.subject caspase 9
dc.subject cowaniin
dc.subject imidazole derivative
dc.subject mitogen activated protein kinase p38
dc.subject nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase
dc.subject protein kinase B
dc.subject pyridine derivative
dc.subject tannin derivative
dc.subject Akt signaling
dc.subject antiproliferative activity
dc.subject apoptosis
dc.subject Article
dc.subject cell death
dc.subject cell nucleus
dc.subject cell structure
dc.subject cell survival
dc.subject cell viability
dc.subject controlled study
dc.subject drug cytotoxicity
dc.subject drug mechanism
dc.subject drug structure
dc.subject human
dc.subject human cell
dc.subject LoVo cell line
dc.subject mitochondrial membrane potential
dc.subject MTT assay
dc.subject priority journal
dc.subject protein expression level
dc.subject protein synthesis
dc.subject Western blotting
dc.subject antagonists and inhibitors
dc.subject cell cycle
dc.subject cell proliferation
dc.subject chemistry
dc.subject colorectal tumor
dc.subject drug effect
dc.subject gene expression regulation
dc.subject MAPK signaling
dc.subject metabolism
dc.subject tumor cell line
dc.subject Caspase 7
dc.subject Caspase 9
dc.subject Cell Cycle
dc.subject Cell Line, Tumor
dc.subject Cell Proliferation
dc.subject Cell Survival
dc.subject Colorectal Neoplasms
dc.subject Gene Expression Regulation, Neoplastic
dc.subject Humans
dc.subject Imidazoles
dc.subject MAP Kinase Signaling System
dc.subject p38 Mitogen-Activated Protein Kinases
dc.subject Poly(ADP-ribose) Polymerases
dc.subject Proto-Oncogene Proteins c-akt
dc.subject Pyridines
dc.subject Tannins
dc.title P38 inhibitor inhibits the apoptosis of cowanin-treated human colorectal adenocarcinoma cells
dc.type Article
dc.rights.holder Scopus
dc.identifier.bibliograpycitation International Journal of Oncology. Vol 52, No.6 (2018), p.2031-2040
dc.identifier.doi 10.3892/ijo.2018.4353


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics